Clinical Trials Browser

OTHER × Immune System Diseases × Tacrolimus × Clear all

Immune System Diseases, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT02294552 2018-01-16

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Phase 2 Completed

200 enrolled

LymphoidMyeloidOther hematologic neoplasm

Immune System Diseases, Leukemia, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT